跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sorbitan
首页
药物
Sorbitan
Experimental
Small Molecule
Sorbitan
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
6
H
12
O
5
CAS 编号
12441-09-7
UNII ID
AV0YTZ4E6J
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PHARMACEUTICAL COMPOSITIONS COMPRISING SORBITAN ESTERS
EP 3156056 B1
申请人: ALKERMES PHARMA IRELAND LTD
优先权: 2011
CN
EP
US
WO
18 件公开
PERSONAL CARE COMPOSITION COMPRISING RETINOID, MODIFIED STARCH AND SORBITAN FATTY ESTER
EP 4440540 B1
申请人: UNILEVER IP HOLDINGS B V
优先权: 2021
CN
EP
US
WO
4 件公开
COMPOSITION FOR OXIDATION DYEING KERATIN FIBRES COMPRISING A CATIONIC CELLULOSE ETHER, A WEAKLY OXYETHYLENATED SORBITAN FATTY ACID ESTER AND OXIDATION DYES
EP 2175830 B1
申请人: ORÉAL L
优先权: 2007
EP
US
WO
4 件公开
Composition comprising two particular oxidation dye precursors, an oxyethylenated fatty acid ester of sorbitan and a fatty acid
US 12263237 B2
申请人: OREAL
优先权: 2020
EP
US
WO
4 件公开
Stable pharmacologically active compositions including vitamin D-containing and corticosteroid compounds with low pH compatibility
US 2008064669 A1
申请人: COHEN RAKEFET
优先权: 2006
CN
US
4 件公开
OPHTHALMIC COMPOSITIONS FOR SOFT CONTACT LENS, METHOD OF ENHANCING WETTABILITY OF SOFT CONTACT LENS, AND METHOD OF INHIBITING TERPENOID ADSORPTION
US 2002010193 A1
申请人: DOI KOJI
优先权: 1997
US
4 件公开
Oral veterinary composition with gabapentin
US 10610498 B2
申请人: CHAIT AUERBACH JAIME SAMUEL
优先权: 2015
EP
US
WO
3 件公开
AZITHROMYCIN NASAL SPRAY FORMULATION
EP 4746892 A1
申请人: AODH LIFESCIENCES PRIVATE LTD
优先权: 2023
CN
EP
WO
3 件公开
Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
US 7700128 B2
申请人: TAKEDA PHARMACEUTICAL
优先权: 2003
CN
US
3 件公开
Surfactant composition
US 8673987 B2
申请人: BEVINAKATTI HANAMANTHSA S
优先权: 2004
CN
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈